Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estrogen therapy after hysteroscopic adhesiolysis for Asherman Syndrome
NCT02726971Phase 2Completed
- Sponsor
- Fuxing Hospital, Capital Medical University
- Start
- Apr 2016
- Primary completion
- Aug 2016
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of estradiol in Asherman syndrome (IUA), sponsored by Fuxing Hospital, Capital Medical University. Started Apr 2016; status: completed.
02
Drugs
estradiol
03
Conditions
Asherman syndrome (IUA)
Beyond the preview
Go deeper on NCT02726971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02726971.